In the crosshairs: NF-κB targets the JNK signaling cascade

Current Medicinal Chemistry: Anti-Inflammatory and Anti-Allergy Agents

Volumn 4, Issue 6, 2005, Pages 569-576

  Pham, Can G ^a   Papa, Salvatore ^a   Bubici, Concetta ^a   Zazzeroni, Francesca ^a,b   Franzoso, Guido ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Apoptosis; Ferritin; Gadd45 ; Inflammation; JNK; NF B; Reactive oxygen species (ROS); TNF

Indexed keywords

ACETYLSALICYLIC ACID; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 8; CONCANAVALIN A; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FERRITIN; GLUCOCORTICOID; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEASOME INHIBITOR; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; X LINKED INHIBITOR OF APOPTOSIS; ZINC FINGER PROTEIN;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOTOXICITY; DOWN REGULATION; GENE TARGETING; HUMAN; IMMUNOREGULATION; INFLAMMATORY DISEASE; IRON STORAGE; LEUKEMIA; MULTIPLE MYELOMA; NONHUMAN; ONCOGENE NEU; ONCOGENE RAS; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 28444453331     PISSN: 15680142     EISSN: None     Source Type: Journal    
DOI: 10.2174/156801405774933188     Document Type: Review

References (58)

1. Danial, N.N.; Korsmeyer, S.J. Cell, 2004, 116, 205.
2. Johnstone, R.W.; Ruefli, A.A.; Lowe, S.W. Cell, 2002, 108,153.
3. Rathmel, J.C.; Thompson, C.B. Cell, 2002, 109, S97.
4. Dickson, D.W. J. Clin. Invest., 2004, 114, 23.
5. Chen, L.F.; Greene, W.C. Nat. Rev. Mol. Cell. Biol., 2004, 5, 392.
6. Wajant, H.; Pfizenmaier, K.; Scheurich, P. Cell Death Differ., 2003, 10, 45.
7. Li, Q.; Verma, I. M. Nat. Rev. Immunol., 2002, 2, 725.
8. Kucharczak, J.; Simmons, M.J.; Fan, Y.; Gelinas, C. Oncogene, 2003, 22, 8961.
9. Orlowski, R.Z.; Baldwin, A.S. Jr. Trends Mol. Med., 2002, 8, 385.
10. Makarov, S. S. Mol. Med. Today, 2000, 6, 441.
11. Karin, M.; Yamamoto, Y.; Wang, Q.M. Nat. Rev. Drug Discov., 2004, 3, 17.
12. De Smaele, E.; Zazzeroni, F.; Papa, S.; Nguyen, D.U.; Jin, R.; Jones, J.; Cong, R.; Franzoso, G. Nature, 2001, 414, 308.
13. Tang, G.; Minemoto, Y.; Dibling, B.; Purcell, N.H.; Li, Z.; Karin, M.; Lin, A. Nature, 2001, 414, 313.
14. Javelaud, D.; Besancon, F. Oncogene, 2001, 20, 4365.
15. Sakon, S.; Xue, X.; Takekawa, M.; Sasazuki, T.; Okazaki, T.; Kojima, Y.; Piao, J.H.; Yagita, H.; Okumura, K.; Doi, T.; Nakano, H. EMBO J., 2003, 22, 3898.
16. Pham, C.G.; Bubici, C.; Zazzeroni, F.; Papa, S.; Alvarez, K.; Jayawardena, S.; DeSmaele, E.; Cong, R.; Beaumont, C.; Torti, F.M.; Torti, S.V.; Franzoso, G. Cell, 2004, 119, 529.
17. Ventura, J.J.; Cogswell, P.; Flavell, R.A.; Baldwin Jr., A.S.; Davis, R.J. Genes Dev., 2004, (published online ahead of print).
18. Beg, A.A.; Sha, W.C.; Bronson, R.T.; Ghosh, S.; Baltimore, D. Nature, 1995, 376, 167.
19. Beg, A.A.; Baltimore, D. Science, 1996, 274, 782.
20. Van Antwerp, D.J.; Martin, S.J.; Kafri, T.; Green, D.R.; Verma, I.M. Science, 1996, 274, 787.
21. Wang, C.; Mayo, M.; Baldwin Jr., A.S. Science, 1996, 274, 784.
22. Liu, Z.G.; Hsu, H.; Goeddel, D.; Karin, M. Cell, 1996, 87, 565.
23. Doi, T. S.; Marino, M. W.; Takahashi, T.; Yoshida, T.; Sakakura, T.; Old, L. J.; Obata, Y. PNAS, 1999, 96, 2994.
24. Rosenfeld, M. E.; Prichard, L.; Shiojiri, N.; Fausto, N. Am. J. Pathol., 2000, 156, 997.
25. Micheau, O.; Tschopp, J. Cell, 2003, 114, 181.
26. Schneider-Brachert, W.; Tchikov, V.; Neumeyer, J.; Jakob, M.; Winoto-Morbach, S.; Held-Feindt, J.; Heinrich, M.; Merkel, O.; Ehrenschwender, M.; Adam, D.; Mentlein, R.; Kabelitz, D.; Schutze, S. Immunity, 2004, 21, 415.
27. Liu, N.; Raja, S.; Zazzeroni, F.; Metkar, S.S.; Shah, R.; Zhang, M.; Wang, Y.; Bromme, D.; Russin, W.A.; Lee, J.C.; Peter, M.E.; Froelich, C.; Franzoso, G.; Ashton-Rickardt, P. G. EMBO J., 2003, 22, 5313.
28. Davis, R.J. Cell, 2000, 103, 239.
29. Chang, L.; Karin, M. Nature, 2001, 410, 37.
30. Kennedy, N.J.; Davis, R.J. Cell Cycle, 2003, 2, 199.
31. Tournier, C.; Hess, P.; Yang, D.D.; Xu, J.; Turner, T.K.; Nimnual, A.; Bar-Sagi, D.; Jones, S.N.; Flavell, R.A.; Davis, R.J. Science, 2000, 288, 870.
32. Sabapathy, K.; Kallunki, T.; David, J.P.; Graef, I.; Karin, M.; Wagner, E.F. J. Exp. Med., 2001, 193, 317.
33. Lei, K.; Nimnual, A.; Zong, W.X.; Kennedy, N.J.; Flavell, R.A.; Thompson, C.B.; Bar-Sagi, D.; Davis, R.J. Mol. Cell Biol., 2002, 22, 4929.
34. Papa, S.; Zazzeroni. F.; Bubici, C.; Jayawardena, S.; Alvarez, K.; Matsuda, S.; Nguyen, D.U.; Pham, C.G.; Nelsbach, A.H.; Melis, T.; DeSmaele, E.; Tang, W.J.; D'Adamio, L.; Franzoso, G. Nat. Cell Biol., 2004, 6, 146.
35. Deng, Y.; Ren, X.; Yang, L.; Lin, Y.; Wu, X. Cell, 2003, 115, 61.
36. Papa, S.; Zazzeroni, F.; Pham, C.G.; Bubici, C.; Franzoso, G. J. Cell Science, 2004, 117, 5197.
37. Maeda, S.; Chang, L.; Li, Z.W.; Luo, J.L.; Leffert, H.; Karin, M. Immunity, 2003, 19, 725.
38. Lamb, J. A.; Ventura, J. J.; Hess, P.; Flavell, R. A.; Davis, R. J. Mol. Cell, 2003, 11, 1479.
39. Boone, D.L.; Lee, E.G.; Libby, S.; Gibson, P.J.; Chien, M.; Chan, F.; Madonia, M.; Burkett, P.R.; Ma, A. Inflam. Bowel Dis., 2002, 8, 201.
40. Lee, E.G.; Boone, D.L.; Chai, S.; Libby, S.; Chien, M.; Lodolce, J.P.; Ma, A. Science, 2000, 289, 2350.
41. Wertz, I.E.; O'Rourke, K.M.; Zhou, H.; Eby, M.; Aravind, L.; Seshagiri, S.; Wu, P.; Wiesmann, C.; Baker, R.; Boone, D.L.; Ma, A.; Koonin, E.V.; Dixit, V.M. Nature, 2004, 430, 694.
42. Zhang, S.Q.; Kovalenko, A.; Cantarella, G.; Wallach, D. Immunity, 2000, 12, 301.
43. Liebermann, D. A.; Hoffmann, B. Oncogene, 2002, 21, 3391.
44. Takekawa, M.; Saito, H. Cell, 1998, 95, 521.
45. Amanullah, A.; Azam, N.; Balliet, A.; Hollander, C.; Hoffman, B.; Fornace, A.; Liebermann, D. Nature, 2003, 424, 741.
46. Zazzeroni, F.; Papa, S.; De Smaele, E.; Franzoso, G. Nature, 2003, 424,742.
47. Tournier, C.; Dong, C.; Turner, T.K.; Jones, S.N.; Flavell, R.A.; Davis, R.J. Genes Dev., 2001, 15, 1419.
48. Salvesen, G.S.; Duckett, C.S. Nat. Rev. Mol. Cell Biol., 2002, 3, 401.
49. Stehlik, C.; de Martin, R.; Kumabashiri, I.; Schmid, J.A.; Binder, B.R.; Lipp, J. J. Exp. Med., 1998, 188, 211.
50. Sanna, M.G.; da SilvaCorreia, J.; Ducrey, O.; Lee, J.; Nomoto, K.; Schrantz, N.; Deveraux, O.L.; Ulevitch, R.J. Mol. Cell. Biol., 2002, 22, 1754.
51. Curtin, J.F.; Donovan, M.; Cotter, T.G. J. Immunol. Methods, 2002, 265, 49.
52. Matsuzawa, A.; Nishitoh, H.; Tobiume, K.; Takeda, K.; Ichijo, H. Antiox. Redox Signal., 2002, 4, 415.
53. Liu, H.; Nishitoh, H.; Ichijo, H.; Kyriakis, J.M. Molec. Cell. Biol., 2000, 20, 2198.
54. Torti, F.M.; Torti, S.V. Blood, 2002, 99, 3505.
55. Tak, P.P.; Firestein, G.S. J. Clin. Invest., 2001, 107, 7.
56. Bernard, D.; Quatannens, B.; Begue, A.; Vandenbunder, B.; Abbadie, C. Cancer Res., 2001, 61, 2656.
57. Delhalle, S.; Deregowski, V.; Benoit, V.; Merville, M.P.; Bours, V. Oncogene, 2002, 21, 3917.
58. St. Clair, D.K.; Porntadavity, S.; Kiningham, K. Methods Enzymol., 2002, 349, 306.